Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
This is a single arm Phase I study of de-intensified hypofractionated radiation therapy for favorable human papilloma virus-associated oropharynx cancer. It will evaluate the tolerability of a de-intensified hypofractionated radiation therapy regimen completed in 3 weeks (with equivalent biologically effective dose to 60 Gy in 30 fractions) with concurrent weekly cisplatin.
Description: CTCAE v5.0
Measure: Clinician-reported acute toxicities Time: 0-3 monthsDescription: CTCAE v5.0
Measure: Clinician-reported late toxicities Time: 3-12 monthsDescription: MD Anderson Dysphagia Inventory (MDADI): 20-100, higher scores mean better quality of life
Measure: Swallowing-related patient-reported quality of life Time: 1-12 monthsDescription: University of Washington QOL questionnaire (UW-QOL): 0-100, higher scores mean better quality of life
Measure: Head and neck patient-reported quality of life Time: 1-12 monthsDescription: University of Michigan Xerostomia questionnaire (XQ): 0-100, higher scores mean worse quality of life
Measure: Xerostomia-related patient-reported quality of life Time: 1-12 monthsDescription: EuroQol-5 dimensions (EQ-5D-5L): 1-5, higher scores mean worse quality of life
Measure: General patient-reported quality of life Time: 1-12 monthsDescription: Dependence on tube feeds defined as daily use of ≥2 nutritional supplements per day via the feeding tube at the time of evaluation
Measure: Feeding tube dependence Time: 1-12 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports